A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
Stephen C. Bowden, David W. Loring
Christoph Leonhard
Shane S. Bush
David Faust
Paul A. Jewsbury
scroll for more
use your arrow keys for more
scroll or use arrow keys for more